You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910
|
---|---|
Published in |
Journal of Clinical Oncology, December 2014
|
DOI | 10.1200/jco.2014.58.0662 |
Pubmed ID | |
Authors |
Thomas M Pisansky, Daniel Hunt, Leonard G Gomella, Mahul B Amin, Alexander G Balogh, Daniel M Chinn, Michael J Seider, Marie Duclos, Seth A Rosenthal, Glenn S Bauman, Elizabeth M Gore, Marvin Z Rotman, Himanshu R Lukka, William U Shipley, James J Dignam, Howard M Sandler |
Abstract |
To determine whether prolonged androgen suppression (AS) duration before radiotherapy improves survival and disease control in prostate cancer. |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 18% |
Spain | 4 | 11% |
Canada | 3 | 8% |
Dominican Republic | 1 | 3% |
Ireland | 1 | 3% |
Japan | 1 | 3% |
Australia | 1 | 3% |
United Arab Emirates | 1 | 3% |
Unknown | 19 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 26 | 68% |
Scientists | 8 | 21% |
Practitioners (doctors, other healthcare professionals) | 4 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Canada | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 146 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 26 | 17% |
Researcher | 23 | 15% |
Student > Ph. D. Student | 17 | 11% |
Student > Postgraduate | 11 | 7% |
Student > Master | 11 | 7% |
Other | 33 | 22% |
Unknown | 28 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 76 | 51% |
Biochemistry, Genetics and Molecular Biology | 5 | 3% |
Agricultural and Biological Sciences | 4 | 3% |
Nursing and Health Professions | 2 | 1% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 1% |
Other | 9 | 6% |
Unknown | 51 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 52. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2022.
All research outputs
#809,996
of 25,371,288 outputs
Outputs from Journal of Clinical Oncology
#1,894
of 22,043 outputs
Outputs of similar age
#10,244
of 359,692 outputs
Outputs of similar age from Journal of Clinical Oncology
#34
of 228 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,043 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,692 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.